既往经尿道前列腺减容术后机器人辅助根治性前列腺切除术的围手术期与术后结局:高容量中心结果
在高容量中心比较368例既往接受经尿道前列腺电切或激光剜除的机器人辅助根治性前列腺切除术患者与4945例无此病史且无中重度BPH症状患者。手术切缘与30天并发症无显著差异,但既往手术组12个月尿控恢复率67% vs 74%、24个月勃起功能恢复率52% vs 62%更低,36个月生化复发无差异。多因素Cox分析显示既往经尿道手术负向影响勃起功能(匹配HR 0.68,95%CI 0.53-0.88;p=0.003)和尿控恢复(HR 0.84,95%CI 0.73-0.97;p=0.015),对生化复发或转移进展无影响。
要点
- 既往经尿道前列腺减容术不增加机器人根治性前列腺切除术的手术切缘阳性或30天并发症风险。
- 既往经尿道手术者12个月尿控恢复率67% vs 74%,24个月勃起功能恢复率52% vs 62%。
- 既往经尿道手术负向影响勃起功能(匹配HR 0.68)和尿控恢复(HR 0.84),但不影响肿瘤学结局。
核心结论
- 由高经验术者行机器人辅助根治性前列腺切除术时,既往经尿道前列腺电切或激光剜除不负面影响手术、并发症相关及肿瘤学结局。
- 既往经尿道前列腺电切或激光剜除负向影响勃起功能和尿控恢复。
研究设计与样本
- 高容量机器人辅助根治性前列腺切除术中心的比较研究,A组368例有经尿道前列腺电切或激光剜除史,B组4945例无此病史且无中重度BPH症状。
- 采用多因素Cox回归分析并经倾向性评分匹配后重复分析。
主要发现
- 手术切缘和30天并发症率无相关差异。
- 12个月尿控恢复率A组67% vs B组74%(p<0.001)。
- 24个月勃起功能恢复率A组52% vs B组62%(p<0.001)。
- 36个月生化复发无复发生存率A组87.3% vs B组87.8%,两组相同。
- 多因素Cox分析:既往经尿道手术负向影响勃起功能恢复(匹配HR 0.68,95%CI 0.53-0.88;p=0.003)和尿控恢复(HR 0.84,95%CI 0.73-0.97;p=0.015),对生化复发或转移进展无影响。
关键数值与推荐
- 12个月尿控恢复率67% vs 74%(p<0.001)。
- 24个月勃起功能恢复率52% vs 62%(p<0.001)。
- 36个月生化复发无复发生存率87.3% vs 87.8%。
- 勃起功能恢复匹配HR 0.68(95%CI 0.53-0.88;p=0.003)。
- 尿控恢复HR 0.84(95%CI 0.73-0.97;p=0.015)。
临床怎么用
- 术前应告知有经尿道前列腺电切或激光剜除史的患者:手术安全性和肿瘤学结局不受影响,但尿控和勃起功能恢复可能更慢。
- 对此类患者制定术后功能康复预期时应参考既往经尿道手术史。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Prostate cancer patients who are scheduled for robot-assisted radical prostatectomy often have a history of transurethral resection or laser enucleation of the prostate as treatment of benign prostatic hyperplasia. We examined if these patients have impaired surgical, functional and oncologic outcomes compared to those who have no symptom burden of moderate to severe benign prostatic hyperplasia and no previous transurethral resection or laser enucleation of the prostate. MATERIALS AND METHODS: We compared 368 robot-assisted radical prostatectomy patients with previous transurethral resection or laser enucleation of the prostate (group A) to 4,945 robot-assisted radical prostatectomy patients without transurethral resection or laser enucleation of the prostate and without moderate or severe benign prostatic hyperplasia symptoms (group B) at a high-volume robot-assisted radical prostatectomy center. Multivariable Cox regression analyses assessed impact of transurethral resection or laser enucleation of the prostate on erectile function and urinary continence recovery, biochemical recurrence or metastatic progression. Analyses were repeated after propensity score matching. RESULTS: No relevant differences in surgical outcomes, such as surgical margin and 30-day complications rates, were observed. Urinary continence recovery rates at 12 months were 67% vs 74% (group A vs B; p <0.001). Erectile function recovery rates at 24 months were 52% vs 62% (p <0.001). Biochemical recurrence-free rates at 36 months were identical, at 87.3% vs 87.8%. Before and after propensity score matching, transurethral resection or laser enucleation of the prostate negatively affected erectile function recovery (matched HR 0.68, 95% CI 0.53-0.88; p=0.003) in multivariable Cox regression analyses. Similarly, transurethral resection or laser enucleation of the prostate had negative effect on urinary continence recovery (HR 0.84, 95% CI 0.73-0.97; p=0.015) but no effect on biochemical recurrence or metastatic progression. CONCLUSIONS: Previous transurethral resection or laser enucleation of the prostate does not negatively impact surgical, complication-related, and oncologic outcomes if the robot-assisted radical prostatectomy is performed by highly experienced surgeons. However, transurethral resection or laser enucleation of the prostate negatively affects erectile function and urinary continence recovery.
引用
- Leyh-Bannurah SR, Liakos N, Oelke M, et al. Perioperative and Postoperative Outcomes of Robot-Assisted Radical Prostatectomy in Prostate Cancer Patients with Prior Transurethral Subvesical Deobstruction: Results of a High-Volume Center. J Urol. 2021. PMID: 33904761. doi:10.1097/JU.0000000000001776
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。